Voyager Therapeutics, Inc. Receivables, Net, Current
Voyager Therapeutics, Inc. (VYGR) had Receivables, Net, Current of $2.93 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2026-08-06
- 2026-06-30: Receivables, Net, Current $2.93M.
- 2026-03-31: Receivables, Net, Current $1.49M.
- 2025-12-31: Receivables, Net, Current $1.76M.
- 2025-09-30: Receivables, Net, Current $3.19M.
| Period end | Receivables, Net, Current |
|---|---|
| 2026-06-30 | $2.93M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.49M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.76M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $3.19M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.67M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.62M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.50M 10-K · filed 2026-03-09 |
| 2024-09-30 | $15.95M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.70M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $837.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $80.15M 10-K · filed 2025-03-11 |
| 2023-03-31 | $25.00M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $10.00M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |